Skip to content
AnalystLens

Estée Lauder Companies 8-K Report, Corporate Update (Jun 3, 2024)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed June 3, 2024
Period End
June 3, 2024
Security
EL
In the record · 2016–202610-K1110-Q338-K126

EL filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Restructuring8-K · Mar ’18Mar ’18
  2. Restructuring8-K · Aug ’20Aug ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Leadership change8-K · Jul ’26Jul ’26

01—Abstract

Summary

Summary of the 8-K filed June 3, 2024. Cited figures are marked; the original filing is the authoritative source.

The Estée Lauder Companies Inc. filed this Form 8-K under Item 8.01 (Other Events) to report that it has completed its acquisition of Deciem Beauty Group Inc. (DECIEM), the Canadian-based multi-brand company.

According to the attached press release (Exhibit 99.1), ELC first invested in DECIEM in 2017, increased its stake to become majority owner in 2021, and then exercised its option to purchase the remaining interests after a three-year period. The remaining interests were closed on May 31, 2024, using cash on hand for an estimated $860 milliona. The total investment, net of cash, approximated $1.7 billion across the three tranches, and these amounts remain subject to post-closing adjustments under the agreement.

DECIEM's flagship brand, The Ordinary, is described as ranking top two in prestige skin care in its home markets of Canada and the U.S. and top four in France, Germany, and the U.K. during the quarter ended March 31, 2024. The company also includes NIOD, a tech-led skin science brand, and AVESTAN, a fragrance brand. The press release places The Ordinary in ELC's tier of scaling brands, each with net sales between $500 millionb and $1 billion, and says DECIEM will expand ELC's skin care portfolio and reach more global consumers, particularly millennial and Gen Z shoppers.

For investors, the filing is primarily a disclosure of a completed acquisition with a stated total investment of approximately $1.7 billionc net of cash, which is the key financial figure. The press release emphasizes strategic expansion in skin care and points to operational efficiencies and profitability gains achieved under ELC's prior partnership, though it does not quantify expected financial contributions. Forward-looking statements carry the usual risks, including integration of the DECIEM business and execution of its long-term strategic plan.

02—Key points

Key Highlights

  1. ELC completed its acquisition of the remaining interests in DECIEM Beauty Group Inc. on May 31, 2024, announced in an 8-K dated June 3, 2024.
  2. The closing was funded with cash on hand for an estimated $860 million, subject to post-closing adjustments.
  3. The total investment in DECIEM, net of cash, approximated $1.7 billion across three tranches, beginning with a 2017 investment.
  4. ELC became majority owner of DECIEM in 2021 before exercising its option to buy the remaining interests after a three-year period.
  5. The Ordinary, DECIEM's flagship brand, ranked top two in prestige skin care in Canada and the U.S. and top four in France, Germany, and the U.K. in the quarter ended March 31, 2024.
  6. The Ordinary sits in ELC's tier of scaling brands, each with net sales between $500 million and $1 billion.
  7. DECIEM's portfolio also includes NIOD and AVESTAN, and the acquisition is positioned to expand ELC's skin care portfolio.

03—Questions

Frequently Asked Questions

  1. How much did The Estée Lauder Companies pay to complete the DECIEM acquisition?

    ELC closed the purchase of the remaining DECIEM interests on May 31, 2024, using cash on hand for an estimated $860 million. The total investment, net of cash, approximated $1.7 billion across the three tranches. Both amounts are subject to post-closing adjustments under the agreement.

  2. What is the relationship between ELC and DECIEM before this acquisition?

    ELC first invested in DECIEM in 2017, increased its stake to become majority owner in 2021, and later exercised its option to purchase the remaining interests after a three-year period.

  3. What brands does DECIEM bring to ELC?

    DECIEM's flagship brand is The Ordinary. Its portfolio also includes NIOD, described as a pioneer in tech-led skin science, and AVESTAN, a fragrance brand. DECIEM is headquartered in Toronto, Canada, and operates five in-house labs there.

  4. What strategic benefit does ELC expect from the acquisition?

    The press release says DECIEM helps expand ELC's skin care portfolio to reach more global consumers, particularly millennial and Gen Z shoppers. It also cites DECIEM's agile, vertically integrated structure and its track record of driving stronger profitability through operational efficiencies under ELC's support.

  5. What risks does the filing identify for the acquisition?

    The forward-looking statements note risks including current economic, geopolitical, and other global conditions, actions by retailers, suppliers, and consumers, competition, the ongoing integration of the DECIEM business, and the ability to implement DECIEM's long-term strategic plan. These are also described in ELC's Form 10-K for the year ended June 30, 2023.

04—Continue

← View all 8-K filings